Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS.

Nature. 1993 Aug 12;364(6438):626-32.

PMID:
8394509
2.

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J.

J Clin Invest. 1993 Jan;91(1):308-18.

3.

Excitatory amino acids as a final common pathway for neurologic disorders.

Lipton SA, Rosenberg PA.

N Engl J Med. 1994 Mar 3;330(9):613-22. Review. No abstract available.

PMID:
7905600
4.

Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain?

Lehmann A, Hagberg H, Orwar O, Sandberg M.

Eur J Neurosci. 1993 Oct 1;5(10):1398-412.

PMID:
7903894
5.

Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion.

Phillis JW, Smith-Barbour M, O'Regan MH, Perkins LM.

Neurochem Res. 1994 Sep;19(9):1125-30.

PMID:
7824064
6.

Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH.

N Engl J Med. 1995 Feb 2;332(5):286-91.

7.

Plasma homocysteine in the acute and convalescent phases after stroke.

Lindgren A, Brattström L, Norrving B, Hultberg B, Andersson A, Johansson BB.

Stroke. 1995 May;26(5):795-800.

8.

Increased transmitter amino acid concentration in human ventricular CSF after brain trauma.

Palmer AM, Marion DW, Botscheller ML, Bowen DM, DeKosky ST.

Neuroreport. 1994 Dec 30;6(1):153-6.

PMID:
7703404
9.

NMDA-dependent superoxide production and neurotoxicity.

Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J.

Nature. 1993 Aug 5;364(6437):535-7.

PMID:
7687749
10.

Can lowering homocysteine levels reduce cardiovascular risk?

Stampfer MJ, Malinow MR.

N Engl J Med. 1995 Feb 2;332(5):328-9. No abstract available.

PMID:
7654269
11.

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG.

Lancet. 1995 Nov 25;346(8987):1395-8.

PMID:
7475822
12.

Temporal profile of neuronal damage in a model of transient forebrain ischemia.

Pulsinelli WA, Brierley JB, Plum F.

Ann Neurol. 1982 May;11(5):491-8.

PMID:
7103425
13.

Delayed neuronal death in the gerbil hippocampus following ischemia.

Kirino T.

Brain Res. 1982 May 6;239(1):57-69.

PMID:
7093691
14.

Regional distribution of homocysteine in the mammalian brain.

Broch OJ, Ueland PM.

J Neurochem. 1984 Dec;43(6):1755-7.

PMID:
6491675
15.

Conductance changes induced by DL-homocysteic acid and N-methyl-DL-aspartic acid in hippocampal neurons.

Hablitz JJ.

Brain Res. 1982 Sep 9;247(1):149-53. No abstract available.

PMID:
6127143
16.

Excitatory actions of homocysteic acid on hippocampal neurons.

Sawada S, Takada S, Yamamoto C.

Brain Res. 1982 Apr 22;238(1):282-5.

PMID:
6123374
17.

Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Simon RP, Swan JH, Griffiths T, Meldrum BS.

Science. 1984 Nov 16;226(4676):850-2.

PMID:
6093256
18.

L-homocysteic acid: an endogenous excitotoxic ligand of the NMDA receptor.

Olney JW, Price MT, Salles KS, Labruyere J, Ryerson R, Mahan K, Frierdich G, Samson L.

Brain Res Bull. 1987 Nov;19(5):597-602.

PMID:
2891418
19.

Glutamate neurotoxicity in cortical cell culture.

Choi DW, Maulucci-Gedde M, Kriegstein AR.

J Neurosci. 1987 Feb;7(2):357-68.

Supplemental Content

Support Center